Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
As of today, Gilead Sciences(GILD) shares are valued at $132.16. The company's market cap stands at 168.82B, with a P/E ratio of 17.84 and a dividend yield of 2.46%.
As of 2026-08-05, Gilead Sciences(GILD) stock has fluctuated between $129.60 and $137.80. The current price stands at $132.16, placing the stock +2.0% above today's low and -4.1% off the high.
Gilead Sciences(GILD) shares are trading with a volume of 11.38M, against a daily average of 7.38M.
During the past year, Gilead Sciences(GILD) stock moved between $108.46 at its lowest and $157.29 at its peak.
During the past year, Gilead Sciences(GILD) stock moved between $108.46 at its lowest and $157.29 at its peak.
GILD News
AIDS Healthcare Foundation publicly criticizes Gilead Sciences (NasdaqGS:GILD) for high profits and restrictive access to affordable HIV treatments in low and m...
Gilead Sciences (NASDAQ:GILD) reported second-quarter 2026 base business sales growth of 10% year over year to $7.6 billion, supported by HIV treatments and pre...
Gilead Sciences expects to report a full-year adjusted loss of 30 cents to 65 cents a share. Stephen Lam / Reuters Gilead Sciences GILD 3.13 %increase; up poin...
Analyst ratings
79%
of 29 ratingsMore GILD News
Global markets are wrestling with shifting inflation signals, changing central bank policies, tighter emissions rules and uneasy trade relations. That mix can u...
UBS says Gilead (GILD) announced that the California Supreme Court ruled in the company’s favor in the state court on the final part of the ongoing TDF litigati...
The California Supreme Court on Monday ruled in favor of Gilead Sciences (GILD) in a case that tested whether drugmakers are obligated to develop safer drugs....
Gilead Sciences (GILD) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confide...
Gilead Sciences (GILD) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confide...
Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the st...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.